• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酸腺苷反应元件结合蛋白1反式激活上皮膜蛋白2,后者是膀胱尿路上皮癌中的一种潜在肿瘤抑制因子。

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.

作者信息

Li Chien-Feng, Wu Wen-Jeng, Wu Wen-Ren, Liao Yu-Jing, Chen Lih-Ren, Huang Chun-Nung, Li Ching-Chia, Li Wei-Ming, Huang Hsuan-Ying, Chen Yi-Ling, Liang Shih-Shin, Chow Nan-Haw, Shiue Yow-Ling

机构信息

Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.

出版信息

Oncotarget. 2015 Apr 20;6(11):9220-39. doi: 10.18632/oncotarget.3312.

DOI:10.18632/oncotarget.3312
PMID:25940704
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4496213/
Abstract

In this study, we report that EMP2 plays a tumor suppressor role by inducing G2/M cell cycle arrest, suppressing cell viability, proliferation, colony formation/anchorage-independent cell growth via regulation of G2/M checkpoints in distinct urinary bladder urothelial carcinoma (UBUC)-derived cell lines. Genistein treatment or exogenous expression of the cAMP responsive element binding protein 1 (CREB1) gene in different UBUC-derived cell lines induced EMP2 transcription and subsequent translation. Mutagenesis on either or both cAMP-responsive element(s) dramatically decreased the EMP2 promoter activity with, without genistein treatment or exogenous CREB1 expression, respectively. Significantly correlation between the EMP2 immunointensity and primary tumor, nodal status, histological grade, vascular invasion and mitotic activity was identified. Multivariate analysis further demonstrated that low EMP2 immunoexpression is an independent prognostic factor for poor disease-specific survival. Genistein treatments, knockdown of EMP2 gene and double knockdown of CREB1 and EMP2 genes significantly inhibited tumor growth and notably downregulated CREB1 and EMP2 protein levels in the mice xenograft models. Therefore, genistein induced CREB1 transcription, translation and upregulated pCREB1(S133) protein level. Afterward, pCREB1(S133) transactivated the tumor suppressor gene, EMP2, in vitro and in vivo. Our study identified a novel transcriptional target, which plays a tumor suppressor role, of CREB1.

摘要

在本研究中,我们报告称,在不同的膀胱尿路上皮癌(UBUC)衍生细胞系中,EMP2通过调控G2/M检查点诱导G2/M期细胞周期阻滞,抑制细胞活力、增殖、集落形成/非锚定依赖性细胞生长,从而发挥肿瘤抑制作用。在不同的UBUC衍生细胞系中,染料木黄酮处理或cAMP反应元件结合蛋白1(CREB1)基因的外源性表达可诱导EMP2转录及随后的翻译。对一个或两个cAMP反应元件进行诱变,分别在未进行染料木黄酮处理或外源性CREB1表达的情况下,显著降低了EMP2启动子活性。我们确定了EMP2免疫强度与原发性肿瘤、淋巴结状态、组织学分级、血管侵犯和有丝分裂活性之间存在显著相关性。多变量分析进一步表明,低EMP2免疫表达是疾病特异性生存率低的一个独立预后因素。在小鼠异种移植模型中,染料木黄酮处理、EMP2基因敲低以及CREB1和EMP2基因双重敲低均显著抑制肿瘤生长,并显著下调CREB1和EMP2蛋白水平。因此,染料木黄酮诱导CREB1转录、翻译并上调pCREB1(S133)蛋白水平。随后,pCREB1(S133)在体外和体内反式激活肿瘤抑制基因EMP2。我们的研究确定了CREB1的一个新的转录靶点,该靶点发挥肿瘤抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/42086358e513/oncotarget-06-9220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/d6f6097757a3/oncotarget-06-9220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/86c6b9833715/oncotarget-06-9220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/da7b6da63e87/oncotarget-06-9220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/3e5100753053/oncotarget-06-9220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/42086358e513/oncotarget-06-9220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/d6f6097757a3/oncotarget-06-9220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/86c6b9833715/oncotarget-06-9220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/da7b6da63e87/oncotarget-06-9220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/3e5100753053/oncotarget-06-9220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cd/4496213/42086358e513/oncotarget-06-9220-g005.jpg

相似文献

1
The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.环磷酸腺苷反应元件结合蛋白1反式激活上皮膜蛋白2,后者是膀胱尿路上皮癌中的一种潜在肿瘤抑制因子。
Oncotarget. 2015 Apr 20;6(11):9220-39. doi: 10.18632/oncotarget.3312.
2
EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.在膀胱尿路上皮癌中,EMP2通过TGFβ/SMAD/SP1轴和P2RX7的募集诱导细胞停滞和凋亡。
Cell Oncol (Dordr). 2021 Oct;44(5):1133-1150. doi: 10.1007/s13402-021-00624-x. Epub 2021 Aug 2.
3
Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.肿瘤组织中双重作用信号介质 ANGPTL4 的表观遗传沉默及其在尿路上皮癌微环境中的过表达。
Oncogene. 2018 Feb 1;37(5):673-686. doi: 10.1038/onc.2017.375. Epub 2017 Oct 16.
4
CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.CMTM4在透明细胞肾细胞癌中常被下调,并发挥肿瘤抑制作用。
J Exp Clin Cancer Res. 2015 Oct 16;34:122. doi: 10.1186/s13046-015-0236-4.
5
Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.敲低 Bmi1 抑制人膀胱癌干细胞样侧群细胞的干性和致瘤性。
Oncol Rep. 2014 Feb;31(2):727-36. doi: 10.3892/or.2013.2919. Epub 2013 Dec 13.
6
Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract.上皮膜蛋白 2 是上尿路尿路上皮癌患者的预后指标。
Am J Pathol. 2013 Sep;183(3):709-19. doi: 10.1016/j.ajpath.2013.05.015. Epub 2013 Jul 6.
7
Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.敲低CREB1可在体外和体内抑制人胃癌的肿瘤生长。
Oncol Rep. 2017 Jun;37(6):3361-3368. doi: 10.3892/or.2017.5636. Epub 2017 May 11.
8
Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.驱动扩增的 BCL6 抑制细胞静止是通过反式抑制 FOXO3 和膀胱尿路上皮癌中 FOXO3 的翻译后修饰来介导的。
Theranostics. 2020 Jan 1;10(2):707-724. doi: 10.7150/thno.39018. eCollection 2020.
9
OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.OASIS/CREB3L1在人类膀胱癌中发生表观遗传沉默,促进肿瘤细胞在体外的扩散和迁移。
Epigenetics. 2014 Dec;9(12):1626-40. doi: 10.4161/15592294.2014.988052.
10
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.IGFBP-5 过表达是上尿路和膀胱尿路上皮癌患者预后不良的一个因素。
J Clin Pathol. 2013 Jul;66(7):573-82. doi: 10.1136/jclinpath-2012-201278. Epub 2013 Mar 28.

引用本文的文献

1
Deciphering the Landscape of GATA-Mediated Transcriptional Regulation in Gastric Cancer.解析胃癌中GATA介导的转录调控格局
Antioxidants (Basel). 2024 Oct 18;13(10):1267. doi: 10.3390/antiox13101267.
2
The Multifaceted Role of Epithelial Membrane Protein 2 in Cancer: from Biomarker to Therapeutic Target.上皮膜蛋白2在癌症中的多方面作用:从生物标志物到治疗靶点
Biomol Ther (Seoul). 2024 Nov 1;32(6):697-707. doi: 10.4062/biomolther.2024.168. Epub 2024 Oct 21.
3
Unraveling the structures, functions and mechanisms of epithelial membrane protein family in human cancers.

本文引用的文献

1
Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.Stathmin 1的过表达是鼻咽癌的一个独立预后指标。
Tumour Biol. 2014 Mar;35(3):2619-29. doi: 10.1007/s13277-013-1345-3. Epub 2013 Nov 12.
2
Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract.上皮膜蛋白 2 是上尿路尿路上皮癌患者的预后指标。
Am J Pathol. 2013 Sep;183(3):709-19. doi: 10.1016/j.ajpath.2013.05.015. Epub 2013 Jul 6.
3
Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach.
解析人类癌症中上皮膜蛋白家族的结构、功能及机制。
Exp Hematol Oncol. 2022 Oct 10;11(1):69. doi: 10.1186/s40164-022-00321-x.
4
Loss of EMP2 Inhibits Melanogenesis of MNT1 Melanoma Cells via Regulation of TRP-2.EMP2缺失通过调控TRP-2抑制MNT1黑色素瘤细胞的黑色素生成。
Biomol Ther (Seoul). 2022 Mar 1;30(2):203-211. doi: 10.4062/biomolther.2022.001.
5
EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.在膀胱尿路上皮癌中,EMP2通过TGFβ/SMAD/SP1轴和P2RX7的募集诱导细胞停滞和凋亡。
Cell Oncol (Dordr). 2021 Oct;44(5):1133-1150. doi: 10.1007/s13402-021-00624-x. Epub 2021 Aug 2.
6
Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.驱动扩增的 BCL6 抑制细胞静止是通过反式抑制 FOXO3 和膀胱尿路上皮癌中 FOXO3 的翻译后修饰来介导的。
Theranostics. 2020 Jan 1;10(2):707-724. doi: 10.7150/thno.39018. eCollection 2020.
7
miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.miR-205 通过靶向 cAMP 反应元件结合蛋白 1 抑制神经母细胞瘤生长。
Oncol Res. 2018 Apr 10;26(3):445-455. doi: 10.3727/096504017X14974834436195. Epub 2017 Jun 26.
8
Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.硫酸酯酶-1过表达提示膀胱及上尿路尿路上皮癌预后不良。
Oncotarget. 2017 Jul 18;8(29):47216-47229. doi: 10.18632/oncotarget.17590.
9
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.影响膀胱尿路上皮癌预后的关键通路和基因的鉴定
Onco Targets Ther. 2017 Mar 20;10:1673-1686. doi: 10.2147/OTT.S131386. eCollection 2017.
10
MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.微小RNA-122通过靶向CREB1抑制胃癌的增殖和侵袭。
Am J Cancer Res. 2017 Feb 1;7(2):323-333. eCollection 2017.
遗传异质性和上位性在膀胱癌易感性和预后中的作用:学习分类器系统方法。
J Am Med Inform Assoc. 2013 Jul-Aug;20(4):603-12. doi: 10.1136/amiajnl-2012-001574. Epub 2013 Feb 26.
4
Prognostic value of cell-cycle regulation biomarkers in bladder cancer.细胞周期调控生物标志物在膀胱癌中的预后价值。
Semin Oncol. 2012 Oct;39(5):524-33. doi: 10.1053/j.seminoncol.2012.08.008.
5
The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.E2F 转录因子 1 反式激活 stathmin 1 在肝癌中的作用。
Ann Surg Oncol. 2013 Nov;20(12):4041-54. doi: 10.1245/s10434-012-2519-8. Epub 2012 Aug 22.
6
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.上尿路尿路上皮癌的预后因素:对当前文献的综合回顾。
Eur Urol. 2012 Jul;62(1):100-14. doi: 10.1016/j.eururo.2012.02.030. Epub 2012 Feb 23.
7
Molecular mechanisms in urinary bladder carcinogenesis.膀胱癌发生的分子机制。
J BUON. 2011 Oct-Dec;16(4):589-601.
8
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.新型基因表达谱与临床列线图联合应用可提高高危膀胱癌患者生存预测的准确性。
Clin Cancer Res. 2012 Mar 1;18(5):1323-33. doi: 10.1158/1078-0432.CCR-11-2271. Epub 2012 Jan 6.
9
Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.植物雌激素通过外在途径诱导细胞凋亡,抑制 HER2 过表达乳腺癌细胞中的核因子-κB 信号通路。
Anticancer Res. 2011 Oct;31(10):3301-13.
10
Involvement of phorbol-12-myristate-13-acetate-induced protein 1 in goniothalamin-induced TP53-dependent and -independent apoptosis in hepatocellular carcinoma-derived cells.佛波醇-12-肉豆蔻酸-13-乙酸酯诱导蛋白 1 参与甘烯诱导的肝癌细胞系中依赖和不依赖 TP53 的细胞凋亡。
Toxicol Appl Pharmacol. 2011 Oct 1;256(1):8-23. doi: 10.1016/j.taap.2011.07.002. Epub 2011 Jul 19.